Clinical Trials Browser

Phase NA × Recruiting × Postoperative Nausea and Vomiting × Clear all

NCT07515027 2026-04-13

Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery

Phase NA Recruiting

Postoperative Nausea and Vomiting

NCT07480785 2026-03-18

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

Phase NA Recruiting

Leiomyoma, Ovarian Neoplasms, Postoperative Nausea and Vomiting, Gallstones